Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial



Khanna, Dinesh, Denton, Christopher P, Jahreis, Angelika, van Laar, Jacob M, Frech, Tracy M, Anderson, Marina E, Baron, Murray, Chung, Lorinda, Fierlbeck, Gerhard, Lakshminarayanan, Santhanam
et al (show 14 more authors) (2016) Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. LANCET, 387 (10038). 2630 - 2640.

Warning
There is a more recent version of this item available.
[thumbnail of 101101617 SSc Ms rev FINAL Tracked.docx] Text
101101617 SSc Ms rev FINAL Tracked.docx - Unspecified

Download (7MB)
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 11 May 2016 09:19
Last Modified: 19 Jan 2023 07:36
DOI: 10.1016/S0140-6736(16)00232-4
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3001199

Available Versions of this Item